Targeting the coding sequence: opposing roles in regulating classical and non-classical MHC class I molecules by miR-16 and miR-744

por Friedrich, Michael, Vaxevanis, Christoforos K, Biehl, Katharina, Mueller, Anja, Seliger, Barbara
Publicado 2020

Correlation of the tumor escape phenotype with loss of PRELP expression in melanoma

por Schäfer, Helene, Subbarayan, Karthikeyan, Massa, Chiara, Vaxevanis, Christoforos, Mueller, Anja, Seliger, Barbara
Publicado 2023

TGF-β inducible epithelial-to-mesenchymal transition in renal cell carcinoma

por Tretbar, Sandy, Krausbeck, Peter, Müller, Anja, Friedrich, Michael, Vaxevanis, Christoforos, Bukur, Juergen, Jasinski-Bergner, Simon, Seliger, Barbara
Publicado 2019

Expression, Regulation and Function of microRNA as Important Players in the Transition of MDS to Secondary AML and Their Cross Talk to RNA-Binding Proteins

por Bauer, Marcus, Vaxevanis, Christoforos, Heimer, Nadine, Al-Ali, Haifa Kathrin, Jaekel, Nadja, Bachmann, Michael, Wickenhauser, Claudia, Seliger, Barbara
Publicado 2020

Identification and characterization of novel CD274 (PD‐L1) regulating microRNAs and their functional relevance in melanoma

por Vaxevanis, Christoforos K., Friedrich, Michael, Tretbar, Sandy Uta, Handke, Diana, Wang, Yuan, Blümke, Juliane, Dummer, Reinhard, Massa, Chiara, Seliger, Barbara
Publicado 2022

Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy

por Vaxevanis, Christoforos K., Bauer, Marcus, Subbarayan, Karthikeyan, Friedrich, Michael, Massa, Chiara, Biehl, Katharina, Al-Ali, Haifa Kathrin, Wickenhauser, Claudia, Seliger, Barbara
Publicado 2022

Altered Spatial Composition of the Immune Cell Repertoire in Association to CD34(+) Blasts in Myelodysplastic Syndromes and Secondary Acute Myeloid Leukemia

por Bauer, Marcus, Vaxevanis, Christoforos, Al-Ali, Haifa Kathrin, Jaekel, Nadja, Naumann, Christin Le Hoa, Schaffrath, Judith, Rau, Achim, Seliger, Barbara, Wickenhauser, Claudia
Publicado 2021

DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine

por Anastasopoulou, Eleftheria A, Tzonis, Panagiotis, Fortis, Sotirios P, Mahaira, Louisa, Vaxevanis, Christoforos, Ardavanis, Alexandros, Mittendorf, Elizabeth A, Peoples, George E, Baxevanis, Constantin N, Papamichail, Michael, Perez, Sonia A
Publicado 2015

Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer

por Fortis, Sotirios P., Sofopoulos, Michael, Sotiriadou, Nectaria N., Haritos, Christoforos, Vaxevanis, Christoforos K., Anastasopoulou, Eleftheria A., Janssen, Nicole, Arnogiannaki, Niki, Ardavanis, Alexandros, Pawelec, Graham, Perez, Sonia A., Baxevanis, Constantin N.
Publicado 2017

Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer

por Fortis, Sotirios P., Sofopoulos, Michael, Sotiriadou, Nectaria N., Haritos, Christoforos, Vaxevanis, Christoforos K., Anastasopoulou, Eleftheria A., Janssen, Nicole, Arnogiannaki, Niki, Ardavanis, Alexandros, Pawelec, Graham, Perez, Sonia A., Baxevanis, Constantin N.
Publicado 2017